Connect Sign In
Blood-based testing for Alzheimer’s disease is gaining prevalence as the need for earlier evaluation grows. The robust biomarker phosphorylated tau 217 (pTau 217) can support more confident diagnosis.
The study, published in the Journal of Clinical Microbiology, highlights the increased sensitivity and advantages of AI-based screening compared with manual microscopy.
Benjamin Bradley, MD, PhD, discusses the current risk of Andes hantavirus and Ebola Bundibugyo in the U.S., ARUP’s response, and testing recommendations.
Genomic sequencing advances have transformed our ability to detect and understand genetic drivers of disease. ARUP’s whole genome sequencing (WGS) facilitates rapid diagnosis and timely intervention.
When Marzia Pasquali, PhD, FACMG, joined ARUP Laboratories in 2001, the state of Utah only included five conditions in its newborn screening program.
For critically ill newborns, swift diagnosis is critical to initiate treatment in time. Rapid whole genome tests sequence the entire genome in days, transforming diagnostic capabilities.
During Cervical Cancer Awareness Month, ARUP Consult® highlights self-collected vaginal specimen testing as an FDA-approved, guideline-supported option to help address HPV screening barriers.
ARUP Laboratories’ dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid assay to aid the public health response to ongoing measles outbreaks.
RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be…
Parasitology had been technologically stagnant for decades until ARUP changed the game. Now, ARUP leverages artificial intelligence (AI) to improve detection of gastrointestinal parasites and ease a laborious testing process.
